About SGO

The Society for Gastrointestinal Oncology (SGO, registered number: 52570930-002-07-18-A), established in October 15, 2010 in Hong Kong, is a global non-profit organization whose principal objective is to promoting collaborative research, evidence-based medicine, medical innovations and continuous medical education in gastrointestinal oncology and finally improve the survival and quality of life of patients by using all medical approaches, resources and expertise available.

Mission of SGO

To improve the survival and quality of life of patients by using all medical approaches, resources and expertise available.

Values of SGO

Collaboration
We pursue a respectful attitude towards international colleagues and operate as a cohesive and highly networked research organization in gastrointestinal oncology.

Research
We respect scientific evidence and are rigorous in conducting gastrointestinal oncology.

Innovation
We promote the development of technology and advocate in gastrointestinal oncology for improvements in oncological research.

Mentorship
We are dedicated to training the next generation of students, researchers and health care professionals.

Goals of SGO

Become one of the foremost society for oncological research in the world
Facilitate GI cancer research and education globally
Promote the timely exchange and dissemination of new GI oncology-related knowledge and discovery
Promote excellence in GI cancer care globally
Strengthen the link in oncological research between Asian and Western countries
Develop international clinical consensus and guidelines
Develop training and mentoring programs